| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | HERON THERAPEUTICS INC | 6,197,198 | 106,778,000 | 44.29% | ||
| 2 | LA JOLLA PHARMACEUTICAL CO | 3,191,165 | 75,918,000 | 31.49% | ||
| 3 | IGNYTA INC COM | 3,972,800 | 24,989,000 | 10.36% | ||
| 4 | Opko Health, Inc. | 14,000,000 | 22,031,000 | 9.14% | PRN | |
| 5 | BIOMARIN | 90,215 | 8,347,000 | 3.46% | ||
| 6 | CYCLACEL PHARMACEUTICALS INC COM PAR | 359,900 | 2,159,000 | 0.90% | ||
| 7 | Life Technologies Corp | 279,425 | 889,000 | 0.37% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001214659-16-014680, filed 2016.11.15).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
